Hims & Hers Health Inc Stock Price, News & Analysis

Hims & Hers Health, Inc. (NYSE: HIMS) appointed Dr. Scott Knoer as its first Chief Pharmacy & Innovation Officer, focusing on pharmacy strategy and innovation. With over two decades of experience, Knoer previously served as the Chief Pharmacy Officer at Cleveland Clinic and CEO of the American Pharmacists Association. Hims & Hers reported strong Q3 2022 results with a 95% revenue increase to $144.8 million and 170,000 new subscriptions, bringing total subscriptions to 991,000. The company is expanding its pharmacy operations with new facilities in Ohio and Arizona.

Hims & Hers Health, Inc. has partnered with ChristianaCare to enhance healthcare access, expanding its network to 10 states and Washington D.C. This collaboration will facilitate patient referrals for complex conditions, integrating ChristianaCare's Center for Virtual Health with Hims & Hers' platform. This move aligns with Hims & Hers' mission of providing high-quality, affordable care, benefiting consumers in Delaware, Maryland, New Jersey, and Pennsylvania. The partnership enhances service offerings, making healthcare more convenient and accessible.

Hims & Hers Health reported a strong Q3 2022 with a revenue of $144.8 million, up 95% year-over-year. The company gained over 170,000 net new subscriptions, totaling 991,000 subscriptions, representing an 80% increase year-over-year. Hims & Hers raised its 2022 revenue guidance to $519-$522 million and expects Adjusted EBITDA of $(20) million to $(18) million. Despite a net loss of $(18.8) million, the company aims for Adjusted EBITDA profitability in Q4 2022, citing operational leverage and consumer adoption.

Hims & Hers Health, Inc. (NYSE: HIMS) will report its third quarter 2022 financial results after the market closes on November 7, 2022. A conference call to discuss the results will be held at 5:00 p.m. ET, accessible via U.S. dialing at (888) 510-2630 and internationally at (646) 960-0137, with conference ID 1704296. Hims & Hers is a consumer-first health platform offering treatments for various conditions, connecting patients with healthcare professionals for prescription fulfillment through a subscription model.

Hims & Hers Health, Inc. (NYSE: HIMS) has appointed Brian O’Shaughnessy as Chief Communications Officer and Josh Krueger as VP of Fulfillment Operations. O’Shaughnessy brings over two decades of experience from Google and Skype, where he led notable product communications. Krueger, formerly at Walmart and Amazon, has significant expertise in fulfillment operations. These hires aim to enhance Hims & Hers’ growth and improve customer experiences, following strong financial results with over $100 million in revenue and 100,000 new subscribers in Q2 2022.

Hims & Hers Health has launched its mobile apps on Android following a successful iOS rollout in Q1 2022. This expansion allows users to engage with the brand 3x more than before. The apps offer features such as subscription management, shipment tracking, and access to medical experts. They include innovative programs designed to improve consumer wellness. The company aims to enhance access to healthcare and wellness solutions, serving a broad range of health conditions through its platform.

Hims & Hers Health reported Q2 2022 revenue of $113.6 million, marking an 87% year-over-year increase. The company achieved over 100k net new subscriptions, totaling 817,000, an 80% increase from the previous year. Hims & Hers raised its full-year 2022 revenue guidance to $470 million to $485 million, with an adjusted EBITDA forecast of $(27) million to $(20) million. The company anticipates adjusted EBITDA profitability within the next four quarters, driven by operational efficiencies and strong platform demand.

Hims & Hers Health, Inc. will announce its second quarter 2022 financial results on August 8, 2022, at 4:15 p.m. E.T.. A conference call will follow at 5:00 p.m. E.T. Participants can join by dialing +1 (888) 510-2630 for U.S. callers or +1 (646) 960-0137 for international callers, with the conference ID #1704296. The call will also be available via a live audio webcast. Hims & Hers offers a multi-specialty telehealth platform and serves a variety of health needs, with operations in the U.S. and the U.K.